| Net Cash Provided by (Used in) Operating Activities |
1.14B |
USD |
+33.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
528M |
USD |
+185% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-3.73B |
USD |
-427% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1.8B |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
764M |
shares |
+3.8% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.06B |
USD |
-717% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
103M |
USD |
-87.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
72M |
USD |
-36.8% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
260M |
USD |
-26.3% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
286M |
USD |
-26.5% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
79M |
USD |
-34.7% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
63M |
USD |
-44.2% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
124M |
USD |
-3.13% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
11M |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
26M |
USD |
-27.8% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
28M |
USD |
-47.2% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
166M |
USD |
-4.05% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
16M |
USD |
-20% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
20M |
USD |
-9.09% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
2.19B |
USD |
+21% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
205M |
USD |
-22.6% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
62M |
USD |
+6.9% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
75M |
USD |
-1.32% |
Q1 2024 |
Q1 2024 |